Concourse Financial Group Securities’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6091 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6807 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6801 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6815 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6814 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6745 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6592 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6442 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6208 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6212 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6032 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5987 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5870 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5851 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5689 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5506 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5334 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5188 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4995 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4861 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4833 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4772 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4575 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4722 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4659 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4539 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4293 |
|